The Next Generation of NeoTYPE™ Hematologic Disease and Solid Tumor Profiles

NeoTYPE Profiles have been enhanced to provide the widest spectrum of molecular profiles available ranging from highly focused to broad genomic coverage

Effective October 16, 2014, NeoTYPE Cancer Profiles have been expanded to include two additional broad pan-tumor profiles, the NeoTYPE Discovery Profile for Solid Tumors and the NeoTYPE Cancer Exome Profile. Combined with the other two intermediate pan-tumor profiles and the 21 cancer-specific NeoTYPE Profiles, NeoGenomics is offering two unique levels of molecular profiling services that center on NGS based testing to fit all your needs. These two levels of services range from the more highly focused cancer-specific testing to wide spectrum tumor testing. Together these services encompass all areas of molecular profiling.

Another modification that allows clients more flexibility is the option to order Tech-Only. The majority of NeoTYPE Cancer Profiles can now have their FISH/Flow Cytometry testing ordered as Tech-Only or Global. This update in conjunction with NeoGenomics’ ever-expanding menu aids in providing the best clinical opportunities for our clients


Advantages of the NeoTYPE™ Next-Gen Cancer Profiles include

  • Breadth and focus:with four large pan-tumor Profiles and 21 targeted, cancer-specific Profiles, NeoGenomics provides the widest variety of actionable tumor profiles available
  • Quantitative results: abnormal reports show percentage mutated gene vs. wild-type
  • Plasma testing option for hematologic disease Profiles: for avoiding bone marrow biopsy in fragile and pediatric patients, or when a bone marrow sample is no longer available
  • Options to customize: individual genes may be added to standard Profiles
  • Enhanced ordering options: the FISH and flow cytometry portion of the Profiles that are pre-configured with this type of testing can now be ordered as Tech-Only or Global
  • Integrated reporting: comprehensive summary of results that includes diagnostic, prognostic, therapeutic and clinical trials information
  • BioPharma ready:can be used in all phases of clinical trials and appropriate as a companion diagnostic

Click to see details of individual targeted Cancer-Specific Profiles or Broad Reach options for a pan-tumor approach.

# #

Ordering Options


NeoGenomics offers unprecedented flexibility in test-ordering by allowing clients to add tests to a standard, pre-configured Profile, or to choose tests individually outside the NeoTYPE™ ordering and reporting structure. In addition, pathology clients can choose the option of Tech-Only FISH and flow cytometry in our Cancer-Specific Profiles.


Adding to an Existing Profile

  • Any of the following genes may be added to any of the Hematologic Disease Profiles: ABL1, ASXL1, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, CUX1, DNMT3A, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, JAK2, JAK3, KDM6A, KIT, KRAS, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2
  • Any of the following genes may be added to any of the Solid Tumor Profiles: ABL1, AKT1, ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, FBXW7, FGFR1, FGFR2, FGFR3, FLT3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, VHL
  • Results of testing for added genes will be included in the Comprehensive NeoTYPE™ report for that Profile

Individual Test Orders

  • Clients may select any combination of tests offered in any of our Cancer-Specific Profiles or the broader-reaching Myeloid Disorders or Precision Solid Tumor Profiles.
  • These results will be issued individually without a comprehensive NeoTYPE™ summary report.

Molecular Testing with FISH/Flow Cytometry Tech-Only Option for Pathologists

  • FISH / Flow components can now be ordered as Tech-Only for any of the Cancer-Specific Profiles that have them.

Getting Started

Order Now

Contact Us

Brochure NeoTYPE